IQuest Enterprises To Acquire Active Pharma

IQuest Enterprises a multi-sector investment group, will purchase Viatris' active pharmaceutical ingredients (API) business in India for an undisclosed sum. As per IQuest Enterprises, the investment firm has entered into a binding deal to acquire Viatris' API activities in India. According to the company, IQuest emerged as the chosen investor after a global competitive offer.

The company will acquire six API production facilities, three each in Vizag and Hyderabad, an R&D center in Hyderabad, and third-party API sales as part of the purchase. "We are excited about our largest investment in the pharmaceutical sector till date. Our investment comes at an opportune time when India is drawing significant attention amongst the global pharma industry," IQuest Enterprises Executive Director Gunupati Swathi Reddy noted. IQuest Enterprises is a multi-sector investment company. It has invested in various entities like AIG Hospitals, CARE Hospitals, and Celon Laboratories, as per business standard.

Viatris, based in the United States, announced in a separate announcement that it has signed an agreement to sell its API business in India to IQuest Enterprises. Viatris will, however, retain some selective R&D skills in API, according to the company. Active Pharma Labs is a leading pharmaceutical education and technology institute. Active Pharma Labs provides hands-on training in pharmaceutical sciences technology, and regulatory compliance that is fully integrated. Active Pharma Labs provides and awards pharmaceutical skills certification to university and college graduates who have finished its programs and met professional excellence standards.